Mutual of America Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Mutual of America Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.51M	Buy	+182,909	New	+$8.78M	0.08%	257
2026 Q1	–	Sell	-193,572	Closed	-$9.62M	–	1400
2025 Q4	$9.62M	Sell	193,572 -5,687	-3%	-$277K	0.1%	193
2025 Q3	$9.52M	Sell	199,259 -13,432	-6%	-$541K	0.1%	201
2025 Q2	$6.7M	Buy	212,691 +10,726	+5%	+$344K	0.07%	311
2025 Q1	$6.61M	Sell	201,965 -114	-0.1%	-$4.04K	0.08%	292
2024 Q4	$7.31M	Sell	202,079 -575	-0.3%	-$20.2K	0.08%	284
2024 Q3	$6.32M	Sell	202,654 -75,782	-27%	-$2.37M	0.07%	361
2024 Q2	$7.45M	Sell	278,436 -42,484	-13%	-$1.23M	0.08%	260
2024 Q1	$10.9M	Sell	320,920 -16,787	-5%	-$500K	0.12%	150
2023 Q4	$9.77M	Sell	337,707 -8,408	-2%	-$223K	0.11%	164
2023 Q3	$9.54M	Sell	346,115 -1,770	-0.5%	-$53.9K	0.12%	161
2023 Q2	$10.5M	Sell	347,885 -4,124	-1%	-$144K	0.12%	150
2023 Q1	$12.8M	Sell	352,009 -12,690	-3%	-$488K	0.15%	113
2022 Q4	$13M	Sell	364,699 -10,202	-3%	-$355K	0.16%	104
2022 Q3	$12.7M	Sell	374,901 -7,843	-2%	-$255K	0.17%	91
2022 Q2	$11.1M	Buy	382,744 +16,452	+4%	+$471K	0.14%	120
2022 Q1	$11.8M	Sell	366,292 -6,217	-2%	-$191K	0.13%	155
2021 Q4	$10.9M	Sell	372,509 -2,823	-0.8%	-$85.6K	0.11%	196
2021 Q3	$10M	Buy	375,332 +59,031	+19%	+$1.58M	0.1%	205
2021 Q2	$9.74M	Sell	316,301 -34,483	-10%	-$1.06M	0.1%	221
2021 Q1	$9.18M	Sell	350,784 -5,441	-2%	-$152K	0.1%	231
2020 Q4	$8.96M	Sell	356,225 -2,241	-0.6%	-$48.2K	0.1%	211
2020 Q3	$7.47M	Sell	358,466 -23,830	-6%	-$541K	0.1%	210
2020 Q2	$9.08M	Buy	382,296 +44,361	+13%	+$980K	0.13%	140
2020 Q1	$6.08M	Sell	337,935 -59,094	-15%	-$1.24M	0.1%	223
2019 Q4	$9.42M	Buy	397,029 +4,939	+1%	+$120K	0.12%	163
2019 Q3	$10.8M	Buy	392,090 +8,073	+2%	+$239K	0.15%	121
2019 Q2	$12.7M	Sell	384,017 -36,782	-9%	-$1.26M	0.18%	85
2019 Q1	$14.7M	Buy	420,799 +4,806	+1%	+$179K	0.21%	67
2018 Q4	$13.8M	Buy	415,993 +54,661	+15%	+$2.35M	0.23%	62
2018 Q3	$18.2M	Buy	361,332 +51,776	+17%	+$2.56M	0.26%	49
2018 Q2	$18.5M	Sell	309,556 -79,715	-20%	-$4.13M	0.28%	46
2018 Q1	$17.8M	Sell	389,271 -1,072	-0.3%	-$44.7K	0.28%	46
2017 Q4	$15.6M	Sell	390,343 -12,222	-3%	-$483K	0.24%	57
2017 Q3	$16.1M	Sell	402,565 -19,603	-5%	-$848K	0.26%	51
2017 Q2	$18.2M	Sell	422,168 -46,876	-10%	-$1.67M	0.31%	42
2017 Q1	$14.7M	Buy	469,044 +21,495	+5%	+$576K	0.26%	50
2016 Q4	$11.3M	Sell	447,549 -44,725	-9%	-$999K	0.21%	69
2016 Q3	$12.2M	Sell	492,274 -54,744	-10%	-$1.24M	0.24%	57
2016 Q2	$11.1M	Buy	547,018 +9,425	+2%	+$167K	0.24%	60
2016 Q1	$8.2M	Sell	537,593 -1,635	-0.3%	-$21.3K	0.18%	92
2015 Q4	$7.25M	Sell	539,228 -29,123	-5%	-$450K	0.16%	111
2015 Q3	$7.97M	Sell	568,351 -61,600	-10%	-$1.15M	0.19%	86
2015 Q2	$10.7M	Sell	629,951 -93,040	-13%	-$1.32M	0.23%	67
2015 Q1	$8.74M	Sell	722,991 -38,724	-5%	-$366K	0.19%	84
2014 Q4	$6.32M	Buy	761,715 +20,962	+3%	+$176K	0.14%	150
2014 Q3	$6.44M	Sell	740,753 -66,810	-8%	-$603K	0.15%	118
2014 Q2	$8.84M	Sell	807,563 -244,587	-23%	-$2.18M	0.21%	69
2014 Q1	$9.41M	Hold	1,052,150	–	–	0.23%	58
2013 Q4	$7.93M	Buy	1,052,150 +388,793	+59%	+$2.72M	0.19%	82
2013 Q3	$4.86M	Buy	663,357 +158,710	+31%	+$1.07M	0.13%	168
2013 Q2	$3.25M	Buy	+504,647	New	+$2.97M	0.1%	281

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mutual of America Capital Management's SUPN Position: Q2 2026 in Review

Mutual of America Capital Management opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 182,909 shares worth $8.51M. The stake represents 0.08% of the portfolio and ranks #257 among its holdings. This is a return to the name: Mutual of America Capital Management previously reported a position in SUPN as recently as Q4 2025.

Mutual of America Capital Management first reported a position in SUPN in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.5M in Q2 2018. 172 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Mutual of America Capital Management held 182,909 shares of Supernus Pharmaceuticals worth $8.51M as of Q2 2026.
Supernus Pharmaceuticals was a new Mutual of America Capital Management position in Q2 2026.
Supernus Pharmaceuticals made up 0.08% of Mutual of America Capital Management's portfolio in Q2 2026, its #257 holding.
Mutual of America Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Mutual of America Capital Management's Supernus Pharmaceuticals position peaked at $18.5M in Q2 2018.
172 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.